|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> PDK1 inhibitor>> Market Analysis Reports |
Market Analysis Reports of PDK1 inhibitor |
|
MTORC1 protein inhibitors - Pipeline Insight, 2022 ... and activation by PDK1. MTORC1 Protein Inhibitors - New mTOR-specific inhibitors came ... with bridged morpholines in pyrazolopyrimidine inhibitors and results showed increased ... for MTORC1 Protein Inhibitors. MTORC1 Protein Inhibitors Report Insights MTORC1 ... 3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) - Drugs In Development, 2021 3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) - Drugs In Development, 2021 SUMMARY According to the recently published report '3 Phosphoinositide Dependent Protein Kinase 1 - Drugs In Development, 2021'; 3 Phosphoinositide Dependent ... 3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update 3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY 3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or ... Sunesis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report ... , develop and commercialize small molecule inhibitors of the human protein Raf kinase ... Limited to develop and commercialize preclinical inhibitors of PDK1 and TAK-580. Sunesis conducts ... |